HK1186732A1 - -芳基咪唑並 噠嗪、 -苯基咪唑並 吡啶、和 -苯基咪唑並 吡嗪衍生物 - Google Patents

-芳基咪唑並 噠嗪、 -苯基咪唑並 吡啶、和 -苯基咪唑並 吡嗪衍生物

Info

Publication number
HK1186732A1
HK1186732A1 HK13114185.1A HK13114185A HK1186732A1 HK 1186732 A1 HK1186732 A1 HK 1186732A1 HK 13114185 A HK13114185 A HK 13114185A HK 1186732 A1 HK1186732 A1 HK 1186732A1
Authority
HK
Hong Kong
Prior art keywords
phenylimidazo
arylimidazo
pyridazine
pyridine
pyrazine derivatives
Prior art date
Application number
HK13114185.1A
Other languages
English (en)
Inventor
羅伯特．
．阿特金森
安迪．
．奧門
詹姆士．
．斐爾
肯尼司．
．黃
艾蜜莉．
．史密斯
Original Assignee
江蘇恒瑞醫藥股份有限公司 江蘇省連雲港市
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江蘇恒瑞醫藥股份有限公司 江蘇省連雲港市 filed Critical 江蘇恒瑞醫藥股份有限公司 江蘇省連雲港市
Publication of HK1186732A1 publication Critical patent/HK1186732A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK13114185.1A 2010-12-22 2013-12-23 -芳基咪唑並 噠嗪、 -苯基咪唑並 吡啶、和 -苯基咪唑並 吡嗪衍生物 HK1186732A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201061426216P 2010-12-22 2010-12-22
US201161514833P 2011-08-03 2011-08-03
US201161523688P 2011-08-15 2011-08-15
PCT/US2011/066837 WO2012088411A1 (en) 2010-12-22 2011-12-22 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives

Publications (1)

Publication Number Publication Date
HK1186732A1 true HK1186732A1 (zh) 2014-03-21

Family

ID=45478596

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13114185.1A HK1186732A1 (zh) 2010-12-22 2013-12-23 -芳基咪唑並 噠嗪、 -苯基咪唑並 吡啶、和 -苯基咪唑並 吡嗪衍生物

Country Status (13)

Country Link
US (1) US8871767B2 (zh)
EP (1) EP2635578B1 (zh)
JP (1) JP6088980B2 (zh)
KR (1) KR101959726B1 (zh)
CN (1) CN103261198B (zh)
AU (1) AU2011348143B2 (zh)
BR (1) BR112013015959A2 (zh)
CA (1) CA2821546C (zh)
HK (1) HK1186732A1 (zh)
MX (1) MX2013007148A (zh)
RU (1) RU2598385C2 (zh)
TW (1) TWI617559B (zh)
WO (1) WO2012088411A1 (zh)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103524535B (zh) * 2013-10-16 2016-07-13 苏州云轩医药科技有限公司 具有刺猬通路拮抗剂活性的胺基噻唑-吡啶杂环化合物
CN103923085B (zh) * 2013-02-25 2016-08-24 苏州云轩医药科技有限公司 具有刺猬通路拮抗剂活性的吡啶杂环化合物及其用途
WO2014151729A1 (en) 2013-03-15 2014-09-25 Irm Llc Compounds and compositions for the treatment of parasitic diseases
US9296754B2 (en) * 2013-03-15 2016-03-29 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
US9233961B2 (en) 2013-03-15 2016-01-12 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
SI3083627T1 (sl) 2013-12-19 2019-01-31 Novartis Ag Derivati (1,2,4)triazolo(1,5-a)pirimidina kot inhibitorji protozoan proteasoma za zdravljenje parazitskih bolezni, kot je lišmanioza
EP3105219B9 (en) 2014-02-13 2018-10-03 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
EP3626713B1 (en) 2014-02-13 2021-09-29 Incyte Corporation Cyclopropylamines for use as lsd1 inhibitors
LT3105226T (lt) 2014-02-13 2019-11-11 Incyte Corp Ciklopropilaminai, kaip lsd1 inhibitoriai
WO2016007727A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007736A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyrazines as lsd1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
TWI714567B (zh) 2015-04-03 2021-01-01 美商英塞特公司 作為lsd1抑制劑之雜環化合物
JP6730309B2 (ja) 2015-04-08 2020-07-29 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 有害生物防除剤としての縮合二環式ヘテロ環誘導体及び中間体生成物
CN106432244B (zh) * 2015-08-04 2020-01-10 江苏恒瑞医药股份有限公司 一种hedgehog信号通路抑制剂的结晶形式及其制备方法
CN106432243B (zh) * 2015-08-04 2020-01-10 江苏恒瑞医药股份有限公司 一种hedgehog信号通路抑制剂的结晶形式及其制备方法
AU2016307233B2 (en) 2015-08-07 2020-12-24 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
KR102710120B1 (ko) 2015-08-12 2024-09-27 인사이트 홀딩스 코포레이션 Lsd1 저해제의 염
TW201718581A (zh) 2015-10-19 2017-06-01 英塞特公司 作為免疫調節劑之雜環化合物
ES2894301T3 (es) 2015-10-26 2022-02-14 Bayer Cropscience Ag Derivados de heterociclos bicíclicos condensados como pesticidas
WO2017087777A1 (en) 2015-11-19 2017-05-26 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2017093180A1 (de) 2015-12-01 2017-06-08 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
CR20180374A (es) 2015-12-22 2018-10-16 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
CN106994121B (zh) * 2016-01-26 2021-07-02 江苏恒瑞医药股份有限公司 一种用于治疗癌症的药物组合物
WO2017144341A1 (de) 2016-02-23 2017-08-31 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
CN107137407B (zh) * 2016-03-01 2021-07-27 江苏恒瑞医药股份有限公司 一种vegfr抑制剂在制备治疗胰腺癌的药物中的用途
CN107137406B (zh) * 2016-03-01 2021-07-02 江苏恒瑞医药股份有限公司 一种Hedgehog信号通路抑制剂在制备治疗EGFR过度表达的癌症的药物中的用途
CN107137403B (zh) * 2016-03-01 2021-07-02 江苏恒瑞医药股份有限公司 一种pi3k/mtor抑制剂在制备治疗胰腺癌的药物中的用途
WO2017174414A1 (de) 2016-04-05 2017-10-12 Bayer Cropscience Aktiengesellschaft Naphthalin-derivate als schädlingsbekämpfungsmittel
MX2018012901A (es) 2016-04-22 2019-06-06 Incyte Corp Formulaciones de inhibidor de demetilasa 1 especifica para lisina (lsd1).
EP3241830A1 (de) 2016-05-04 2017-11-08 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
AR108396A1 (es) 2016-05-06 2018-08-15 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
EP3464279B1 (en) 2016-05-26 2021-11-24 Incyte Corporation Heterocyclic compounds as immunomodulators
IL263825B (en) 2016-06-20 2022-08-01 Incyte Corp Heterocyclic compounds as immunomodulators
EP4257191A3 (en) 2016-06-21 2023-11-22 Orion Ophthalmology LLC Heterocyclic prolinamide derivatives
EP3472151A4 (en) 2016-06-21 2020-03-04 Orion Ophthalmology LLC CARBOCYCLIC PROLINAMIDE DERIVATIVES
WO2018013789A1 (en) 2016-07-14 2018-01-18 Incyte Corporation Heterocyclic compounds as immunomodulators
AU2017298972B2 (en) 2016-07-19 2021-03-04 Bayer Cropscience Aktiengesellschaft Condensed bicyclic heterocycle derivatives as pest control agents
WO2018033455A1 (de) 2016-08-15 2018-02-22 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
MA46045A (fr) 2016-08-29 2021-04-28 Incyte Corp Composés hétérocycliques utilisés comme immunomodulateurs
JP7165126B2 (ja) 2016-09-19 2022-11-02 バイエル・クロップサイエンス・アクチェンゲゼルシャフト ピラゾロ［１，５－ａ］ピリジン誘導体及びそれの殺有害生物剤としての使用
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz
CA3047980A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
US10308644B2 (en) 2016-12-22 2019-06-04 Incyte Corporation Heterocyclic compounds as immunomodulators
US20180179179A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds as immunomodulators
EP3558989B1 (en) 2016-12-22 2021-04-14 Incyte Corporation Triazolo[1,5-a]pyridine derivatives as immunomodulators
CN110382485B (zh) 2017-01-10 2022-05-10 拜耳公司 作为害虫防治剂的杂环烯衍生物
AR113206A1 (es) 2017-01-10 2020-02-19 Bayer Cropscience Ag Derivados heterocíclicos como pesticidas
WO2018138050A1 (de) 2017-01-26 2018-08-02 Bayer Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
JP7119001B2 (ja) 2017-04-24 2022-08-16 バイエル・アクチエンゲゼルシヤフト 有害生物防除剤としての縮合二環式ヘテロ環式化合物誘導体
KR20200088398A (ko) * 2017-11-14 2020-07-22 칠드런'즈 메디컬 센터 코포레이션 인간 면역 반응을 조정하기 위한 이미다조피리미딘의 용도
US11673891B2 (en) 2017-11-14 2023-06-13 Dana-Farber Cancer Institute, Inc. Imidazopyrimidine compounds and uses thereof
EP3305786A3 (de) 2018-01-22 2018-07-25 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
JP2021514949A (ja) 2018-02-21 2021-06-17 バイエル・アクチエンゲゼルシヤフト 有害生物防除剤としての縮合二環式ヘテロ環誘導体
HRP20230090T1 (hr) 2018-03-30 2023-03-17 Incyte Corporation Heterociklički spojevi kao imunomodulatori
TW202425987A (zh) 2018-05-11 2024-07-01 美商英塞特公司 作為免疫調節劑之雜環化合物
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
EP3931193A1 (en) 2019-02-26 2022-01-05 Bayer Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides
JP7535532B2 (ja) 2019-02-26 2024-08-16 バイエル・アクチエンゲゼルシヤフト 有害生物防除剤としての縮合二環式複素環式誘導体
US11753406B2 (en) 2019-08-09 2023-09-12 Incyte Corporation Salts of a PD-1/PD-L1 inhibitor
US11401279B2 (en) 2019-09-30 2022-08-02 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators
WO2021096849A1 (en) 2019-11-11 2021-05-20 Incyte Corporation Salts and crystalline forms of a pd-1/pd-l1 inhibitor
US11718622B2 (en) 2020-03-16 2023-08-08 Exelixis Inc. Heterocyclic adenosine receptor antagonists
CN112047950B (zh) * 2020-09-14 2023-07-25 华东师范大学 咪唑并吡嗪类衍生物及其合成方法和应用
US11760756B2 (en) 2020-11-06 2023-09-19 Incyte Corporation Crystalline form of a PD-1/PD-L1 inhibitor
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
WO2022099071A1 (en) 2020-11-06 2022-05-12 Incyte Corporation Process for making a pd-1/pd-l1 inhibitor and salts and crystalline forms thereof
GB202019622D0 (en) * 2020-12-11 2021-01-27 Adorx Therapeutics Ltd Antagonist compounds
CN114292226B (zh) * 2021-11-29 2023-04-18 沈阳药科大学 具有异羟肟酸结构的化合物及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001478A1 (en) * 1987-08-07 1989-02-23 The Australian National University ARYLOXY- AND ARALKYLTHIO-IMIDAZO[1,2-b]PYRIDAZINES
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
TWI312347B (en) * 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
WO2003011219A2 (en) * 2001-07-27 2003-02-13 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
KR20060110344A (ko) * 2003-12-31 2006-10-24 쉐링-프라우 리미티드 이미다조[1,2-ｂ]피리다진 유도체를 사용하여 동물에서기생충을 방제하는 방법
EP1786858A4 (en) * 2004-08-31 2009-09-16 Hyperion Catalysis Int CONDUCTIVE THERMODURCIS BY EXTRUSION
WO2006050506A1 (en) * 2004-11-03 2006-05-11 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
US20090099175A1 (en) 2006-03-01 2009-04-16 Arrington Mark P Phosphodiesterase 10 inhibitors
EP1845098A1 (en) * 2006-03-29 2007-10-17 Ferrer Internacional, S.A. Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
KR20090063220A (ko) * 2006-08-24 2009-06-17 오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 말초 벤조디아제핀 수용체를 표적화하기 위한 플루오르화된리간드
WO2008029152A2 (en) * 2006-09-08 2008-03-13 Summit Corporation Plc Treatment of duchenne muscular dystrophy
EP1964841A1 (en) * 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]azine and their use as pharmaceuticals
FR2918061B1 (fr) * 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
WO2009027733A1 (en) 2007-08-24 2009-03-05 Astrazeneca Ab (2-pyridin-3-ylimidazo[1,2-b]pyridazin-6-yl) urea derivatives as antibacterial agents
JP4858388B2 (ja) 2007-09-28 2012-01-18 ソニー株式会社 固体撮像装置、駆動制御方法、および撮像装置
CN102617578B (zh) * 2007-11-02 2014-08-20 和记黄埔医药（上海）有限公司 一种咪唑衍生物及其医药用途
WO2009060197A1 (en) 2007-11-08 2009-05-14 Centro Nacional De Investigaciones Oncologicas (Cnio) Imidazopyridazines for use as protein kinase inhibitors
RU2364597C1 (ru) * 2007-12-14 2009-08-20 Андрей Александрович Иващенко ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
JP2011506487A (ja) * 2007-12-21 2011-03-03 ザ・ユニバーシティ・オブ・シドニー トランスロケータータンパク質リガンド
EP2103614A1 (en) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
ES2548571T3 (es) 2009-04-02 2015-10-19 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii Derivados de imidazo[2,1-b][1,3,4]tiadiazol
WO2010119264A1 (en) 2009-04-16 2010-10-21 Centro Nacional De Investigaciones Oncólogicas (Cnio) Imidazopyrazines for use as kinase inhibitors
EP2427463A1 (en) 2009-05-05 2012-03-14 Limited Liability Company "Innovative Pharma" Imidazo [1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment
EP2480549B1 (en) 2009-09-24 2015-04-08 Fundación Centro Nacional De Investigaciones Oncológicas Carlos III Fused imidazo[3,2-d]pyrazines as PI3 kinase inhibitors
KR20120111739A (ko) 2009-12-31 2012-10-10 센트로 내셔널 드 인베스티가시오네스 온콜로지카스 (씨엔아이오) 키나제 억제제로서의 사용을 위한 삼환식 화합물
CA2787714C (en) 2010-01-22 2019-04-09 Joaquin Pastor Fernandez Inhibitors of pi3 kinase
WO2011101644A1 (en) 2010-02-18 2011-08-25 Centro Nacional De Investigaciones Oncologicas (Cnio) Triazolo [4, 5 - b] pyridin derivatives
US20130131057A1 (en) 2010-05-13 2013-05-23 Centro Nacional De Investigaciones Oncologicas (Cnio New bicyclic compounds as pi3-k and mtor inhibitors
EP2444084A1 (en) 2010-10-21 2012-04-25 Centro Nacional de Investigaciones Oncológicas (CNIO) Use of PI3K inibitors for the treatment of obesity

Also Published As

Publication number Publication date
KR20140019311A (ko) 2014-02-14
US20120178751A1 (en) 2012-07-12
CA2821546C (en) 2019-03-05
MX2013007148A (es) 2013-11-01
CN103261198B (zh) 2016-06-08
US8871767B2 (en) 2014-10-28
AU2011348143A1 (en) 2013-06-20
JP2014500331A (ja) 2014-01-09
TWI617559B (zh) 2018-03-11
WO2012088411A1 (en) 2012-06-28
RU2598385C2 (ru) 2016-09-27
BR112013015959A2 (pt) 2018-07-10
CN103261198A (zh) 2013-08-21
CA2821546A1 (en) 2012-06-28
JP6088980B2 (ja) 2017-03-01
TW201307342A (zh) 2013-02-16
EP2635578B1 (en) 2015-12-16
RU2013133881A (ru) 2015-01-27
AU2011348143B2 (en) 2016-09-08
KR101959726B1 (ko) 2019-03-19
EP2635578A1 (en) 2013-09-11

Similar Documents

Publication Publication Date Title
HK1186732A1 (zh) -芳基咪唑並 噠嗪、 -苯基咪唑並 吡啶、和 -苯基咪唑並 吡嗪衍生物
HK1253364A1 (zh) 1h-吡唑並[3，4-b]吡啶及其治療應用
IL225232A0 (en) History of imidazo[1,2–b]pyridazine and imidazo[4,5,b]pyridine as jak inhibitors
HK1216174A1 (zh) 氨基取代的咪唑並 吡啶羧酰胺和它們的用途
EP2387315A4 (en) IMIDAZO [1,2-A] PYRIDINES AND IMIDAZO [1,2-B] PYRIDAZINES AS MARK KINASE INHIBITORS
HK1185881A1 (zh) 取代的咪唑並 噠嗪
HK1248676A1 (zh) 咪唑並[1，2-a]吡啶類化合物及其合成及使用方法
PH12013501402A1 (en) Mesoionic Pyrido [1,2 -A] Pyrimidine Pesticides
HK1170738A1 (zh) 咪唑並 噠嗪衍生物及其作為 抑制劑的用途
IL222977A0 (en) Novel 3,5- disubstituted-3 h-imidazolo[5-b]pyridine and 3,5-disubstituted-3h-[1.2.3]triazolo[4,5]py
HK1207374A1 (zh) 作為激酶抑制劑的咪唑並 噠嗪衍生物
HK1221469A1 (zh) -芳基-取代的咪唑並 吡啶及其用途
ZA201307511B (en) Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses
IL221479A0 (en) Triazolo [4,5-b] pyridin derivatives
IL211141A0 (en) 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof, and therapeutic application thereof
HK1188792A1 (zh) 二環苯衍生物取代的 -二氫- -吡咯並 苯並二氮雜䓬和 -吡咯並 苯並二氮雜䓬新抗真菌劑
EP2565194A4 (en) Imidazo [1,2-A] pyridine
HK1206355A1 (zh) 哌嗪並 吲哚- -酮和 二氮雜䓬並 吲哚- -酮
ZA201303772B (en) Antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]-benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines sunstituted with phenyl derivatives
IL229181A (en) Antifungals 5, 6 - Dihydro - 4h - Pyrolo [1, 2a - [4,1] benzo - diazepines and 6h - Pyrolo [2,1 - a] benzodiazepines preserved with heterocyclic history
AU2011246168A1 (en) Imidazo[1,2-a]pyridine derivative

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221225